首页> 外文期刊>Neurocritical Care >Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios
【24h】

Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios

机译:重组激活因子VII在国际正常化比率正常的凝血性非血友病神经外科患者中颅内血肿清除的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Recombinant activated Factor VII (rFVIIa) has recently gained popularity for rapid reversal of coagulopathy during operative neurosurgery. Patients undergoing chronic subdural hematoma (CSDH) or epidural hematoma (EDH) evacuation often have their coagulation status judged by preoperative international normalized ratio (INR). We present our experience in two patients with significant clinical coagulopathy who were successfully reversed with rFVIIa in the setting of normal INR.
机译:重组激活因子VII(rFVIIa)最近在手术神经外科手术中快速逆转凝血病方面广受欢迎。接受慢性硬脑膜下血肿(CSDH)或硬膜外血肿(EDH)排空的患者通常通过术前国际标准化比率(INR)判断其凝血状态。我们介绍了我们在两名患有严重临床凝血病的患者中的经验,这些患者在正常INR的情况下成功地用rFVIIa逆转。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号